144 related articles for article (PubMed ID: 36352147)
41. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
42. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
44. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
45. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
46. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
47. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
48. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
49. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
50. Surface receptor CD177/NB1 does not confer a recruitment advantage to neutrophilic granulocytes during human peritonitis.
Wang L; Ge S; Agustian A; Hiss M; Haller H; von Vietinghoff S
Eur J Haematol; 2013 May; 90(5):436-7. PubMed ID: 23461681
[No Abstract] [Full Text] [Related]
51. Combined utility of CD177, P53, CD105 and c-kit immunohistochemical stains improves the detection of myelodysplastic syndrome.
Aladily TN; Obiedat S; Bustami N; Alhesa A; Altantawi AM; Khader M; Mansour AT
Ann Diagn Pathol; 2021 Dec; 55():151810. PubMed ID: 34482217
[TBL] [Abstract][Full Text] [Related]
52. A Comprehensive Pan-cancer Analysis of the Biological Immunomodulatory Function and Clinical Value of
Wang Y; Guan L; Zhao Y; Yang Y; Wang Y; Feng S; Zou A; Li Y; Zhou B; Zhang D; Che W; Liu F
J Cancer; 2024; 15(2):508-525. PubMed ID: 38169519
[No Abstract] [Full Text] [Related]
53. Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
Liu W; Jiang Q; Sun C; Liu S; Zhao Z; Wu D
BMC Cancer; 2022 Feb; 22(1):192. PubMed ID: 35184747
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer.
Pi YN; Guo JN; Lou G; Cui BB
Cancer Cell Int; 2021 Dec; 21(1):639. PubMed ID: 34852825
[TBL] [Abstract][Full Text] [Related]
55. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
56. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
57. O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer.
Zhou L; Wu H; Bai X; Min S; Zhang J; Li C
Pathol Oncol Res; 2022; 28():1610554. PubMed ID: 36110252
[TBL] [Abstract][Full Text] [Related]
58. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
Li N; Yu K; Lin Z; Zeng D
Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
[TBL] [Abstract][Full Text] [Related]
59.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
60. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]